Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Predicting disease progression in amyotrophic lateral sclerosis with machine learning using wearable sensor measurements
EF 2020-21
Résumé
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative motor neuron disease with an estimated incidence of 2 per 100,000 per year in Canada. Progressive disability due to weakness inevitably leads to death in an average of 3 years from symptom onset. There is currently no cure. Patients make significant sacrifices to participate in research, but differences in the way individuals progress and difficulty monitoring disease are two reasons for the failure of over 50 clinical trials in ALS. Our objective is to use smart watches to monitor the way patients move and develop a more accurate measure of disease progression that can optimize clinical trials. We will collect data in patients across Canada over a 12-month period. We will use machine learning to identify unique features in each patient and train algorithms to accurately predict disease progression in real time. This technology would allow patients to participate in clinical research without frequent in-person visits, while improving the quality of clinical trial data. Our objective is to develop a new precise and cost-effective digital biomarker of ALS disease progression for use in future clinical trials and clinical practice.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449382
Name
Jewett Gordon
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predicting disease progression in amyotrophic lateral sclerosis with machine learning using wearable sensor measurements
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Clinical Outcome Measures; Machine Learning; Wearable Sensors
Abstract
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative motor neuron disease with an estimated incidence of 2 per 100,000 per year in Canada. Progressive disability due to weakness inevitably leads to death in an average of 3 years from symptom onset. There is currently no cure. Patients make significant sacrifices to participate in research, but differences in the way individuals progress and difficulty monitoring disease are two reasons for the failure of over 50 clinical trials in ALS. Our objective is to use smart watches to monitor the way patients move and develop a more accurate measure of disease progression that can optimize clinical trials. We will collect data in patients across Canada over a 12-month period. We will use machine learning to identify unique features in each patient and train algorithms to accurately predict disease progression in real time. This technology would allow patients to participate in clinical research without frequent in-person visits, while improving the quality of clinical trial data. Our objective is to develop a new precise and cost-effective digital biomarker of ALS disease progression for use in future clinical trials and clinical practice.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jewett, Gordon
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~